Posts Tagged ‘by Amanda Conschafter – blog editor’

GAfPA “NOR-SWITCH” Paper Explores Impact of Biosimilar Switching Research

Data from a clinical study in Norway may soon explain the effects of switching stable patients from a biologic medicine, infliximab, to its biosimilar counterpart.

Read More

New National Coalition for Infant Health Video Introduces the RSV “Gap Baby”

Most young children encounter what’s known as Respiratory Syncytial Virus, or RSV, before age two. It’s a common seasonal virus with flu-like symptoms. But as

Read More

New AfPA Video Identifies 3 Traits of a Workable Opioid Abuse Solution

Opioid and heroin abuse is an epidemic that kills 78 Americans every day, explains a new video from the Alliance for Patient Access. But as

Read More

Newborns Affected by Neonatal Abstinence Syndrome Triple

A condition that causes newborns of substance-addicted mothers to experience withdrawal symptoms is on the rise. According to data from the Centers for Disease Control

Read More

New Data Spark Debate on Cost and Value of Breakthrough Cholesterol Meds

A new analysis calls for drastic price reductions for PCSK9 inhibitors, breakthrough lipid-lowering medications. Data published in the Journal of the American Medical Association suggest

Read More

GAfPA Asks: What are the Critical International Barriers to Patient Access?

Healthy lives and well-being for all are among the United Nations’ Sustainable Development Goals for 2030. The U.N. calls for “access to quality essential health-care

Read More

Hospitals Innovate on Pain Management and Opioid Abuse

Opioid-related deaths have tripled since 1999. Now, innovative hospitals are combatting opioid abuse by rethinking how they help patients manage surgical pain. In its recent

Read More

New Study: Aligning Rx Refill Dates Improves Patient Adherence

New research confirms that patients are more likely to follow their medication regimen if they receive all prescription drugs at the same time each month.

Read More

AfPA and CancerCare Explore the Cancer Treatment Experience

Cancer patients may feel under-informed about their diagnosis, overwhelmed by out-of-pocket expenses and unable to carry out day-to-day activities – despite being confident about their

Read More

Health Plan’s Cost Cutting Fuels Non-Medical Switching Worries

Biosimilar medications designed to give patients more options may instead become health plans’ newest tool for limiting patient access. On August 2 CVS Health revealed

Read More
Back to Top